Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3746

Updated: J&J to buy Intra-Cellular for $14.6B in latest neuroscience bet

$
0
0
Johnson & Johnson is acquiring Intra-Cellular Therapies for $14.6 billion in the biggest biotech M&A transaction since 2023. The deal signals growing excitement in neuroscience after several large pharma companies walked away from the space ...

Viewing all articles
Browse latest Browse all 3746